{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:49:12Z","timestamp":1773463752036,"version":"3.50.1"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,14]]},"DOI":"10.1248\/bpb.b25-00671","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:11:54Z","timestamp":1773439914000},"page":"480-490","source":"Crossref","is-referenced-by-count":0,"title":["Involvement of Ca&lt;sub&gt;v&lt;\/sub&gt;3.2 T-Type Ca&lt;sup&gt;2+&lt;\/sup&gt; Channels and the Role of Endogenous Estrogen in Pruritus: Evidence from a Fundamental Study and Cross-Sectional Analysis of Pharmacy Claims Data"],"prefix":"10.1248","volume":"49","author":[{"given":"Shotaro","family":"Kurahashi","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"},{"name":"Sugi Pharmacy Co., Ltd., Obu, Aichi 474\u20130011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"},{"name":"School of Pharmacy, Hyogo Medical University, 1\u20133\u20136 Minatojima, Chuo-ku, Kobe 650\u20138530, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"},{"name":"Fuso Pharmaceutical Industries, Ltd., 2\u20133\u201330 Morinomiya, Joto-ku, Osaka 536\u20138523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiri","family":"Mishima","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seira","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Kino","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Ashida","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Minamino","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyo","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Sugi Pharmacy Co., Ltd., Obu, Aichi 474\u20130011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"},{"name":"Sugi Pharmacy Co., Ltd., Obu, Aichi 474\u20130011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Sakakibara","sequence":"additional","affiliation":[{"name":"Sugi Pharmacy Co., Ltd., Obu, Aichi 474\u20130011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okada","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, University of Toyama, 3190 Gofuku, Toyama 930\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Toyooka","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, University of Toyama, 3190 Gofuku, Toyama 930\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Tsubota","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsufumi","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology &amp; Pathophysiology, Faculty of Pharmacy, Kindai University, 3\u20134\u20131 Kowakae, Higashi-Osaka, Osaka 577\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zachariae R, Lei U, Haedersdal M, Zachariae C. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale. <i>Acta Derm. Venereol.<\/i>, <b>92<\/b>, 508\u2013514 (2012).","DOI":"10.2340\/00015555-1221"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Erturk IE, Arican O, Omurlu IK, Sut N. Effect of the pruritus on the quality of life: a preliminary study. <i>Ann. Dermatol.<\/i>, <b>24<\/b>, 406\u2013412 (2012).","DOI":"10.5021\/ad.2012.24.4.406"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zachariae R, Zachariae CO, Lei U, Pedersen AF. Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. <i>Acta Derm. Venereol.<\/i>, <b>88<\/b>, 121\u2013127 (2008).","DOI":"10.2340\/00015555-0371"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. <i>Arch. Dermatol.<\/i>, <b>147<\/b>, 1153\u20131156 (2011).","DOI":"10.1001\/archdermatol.2011.178"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Guo CJ, Grabinski NS, Liu Q. Peripheral Mechanisms of Itch. <i>J. Invest. Dermatol.<\/i>, <b>142<\/b>, 31\u201341 (2022).","DOI":"10.1016\/j.jid.2021.10.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sekiguchi F, Kawabata A. T-type calcium channels: functional regulation and implication in pain signaling. <i>J. Pharmacol. Sci.<\/i>, <b>122<\/b>, 244\u2013250 (2013).","DOI":"10.1254\/jphs.13R05CP"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Harding EK, Zamponi GW. Central and peripheral contributions of T-type calcium channels in pain. <i>Mol. Brain<\/i>, <b>15<\/b>, 39 (2022).","DOI":"10.1186\/s13041-022-00923-w"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gadotti VM, Kreitinger JM, Wageling NB, Budke D, Diaz P, Zamponi GW. Ca<sub>v<\/sub>3.2 T-type calcium channels control acute itch in mice. <i>Mol. Brain<\/i>, <b>13<\/b>, 119 (2020).","DOI":"10.1186\/s13041-020-00663-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sekiguchi F, Tsubota M, Kawabata A. Sulfide and polysulfide as pronociceptive mediators: Focus on Ca<sub>v<\/sub>3.2 function enhancement and TRPA1 activation. <i>J. Pharmacol. Sci.<\/i>, <b>155<\/b>, 113\u2013120 (2024).","DOI":"10.1016\/j.jphs.2024.04.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tomita S, Sekiguchi F, Kasanami Y, Naoe K, Tsubota M, Wake H, Nishibori M, Kawabata A. Ca<sub>v<\/sub>3.2 overexpression in L4 dorsal root ganglion neurons after L5 spinal nerve cutting involves Egr-1, USP5 and HMGB1 in rats: an emerging signaling pathway for neuropathic pain. <i>Eur. J. Pharmacol.<\/i>, <b>888<\/b>, 173587 (2020).","DOI":"10.1016\/j.ejphar.2020.173587"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tsubota M, Matsui K, Nakano M, Kajitani R, Ishii Y, Tomochika K, Nishikawa Y, Fukushi S, Yamagata A, Sekiguchi F, Okada T, Toyooka N, Kawabata A. Essential role of Ca<sub>v<\/sub>3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice. <i>Eur. J. Pharmacol.<\/i>, <b>887<\/b>, 173576 (2020).","DOI":"10.1016\/j.ejphar.2020.173576"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hiramoto S, Tsubota M, Yamaguchi K, Okazaki K, Sakaegi A, Toriyama Y, Tanaka J, Sekiguchi F, Ishikura H, Wake H, Nishibori M, Nguyen HD, Okada T, Toyooka N, Kawabata A. Cystitis-related bladder pain involves ATP-dependent HMGB1 release from macrophages and its downstream H<sub>2<\/sub>S\/Ca<sub>v<\/sub>3.2 signaling in mice. <i>Cells<\/i>, <b>9<\/b>, 1748 (2020).","DOI":"10.3390\/cells9081748"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tomita S, Sekiguchi F, Deguchi T, Miyazaki T, Ikeda Y, Tsubota M, Yoshida S, Nguyen HD, Okada T, Toyooka N, Kawabata A. Critical role of Ca<sub>v<\/sub>3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice. <i>Toxicology<\/i>, <b>413<\/b>, 33\u201339 (2019).","DOI":"10.1016\/j.tox.2018.12.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tsubota M, Okawa Y, Irie Y, Maeda M, Ozaki T, Sekiguchi F, Ishikura H, Kawabata A. Involvement of the cystathionine- \u03b3-lyase\/Ca<sub>v<\/sub>3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome. <i>Neuropharmacology<\/i>, <b>133<\/b>, 254\u2013263 (2018).","DOI":"10.1016\/j.neuropharm.2018.01.037"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Matsui K, Tsubota M, Fukushi S, Koike N, Masuda H, Kasanami Y, Miyazaki T, Sekiguchi F, Ohkubo T, Yoshida S, Mukai Y, Oita A, Takada M, Kawabata A. Genetic deletion of Ca<sub>v<\/sub>3.2 T-type calcium channels abolishes H<sub>2<\/sub>S-dependent somatic and visceral pain signaling in C57BL\/6 mice. <i>J. Pharmacol. Sci.<\/i>, <b>140<\/b>, 310\u2013312 (2019).","DOI":"10.1016\/j.jphs.2019.07.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang XL, Tian B, Huang Y, Peng XY, Chen LH, Li JC, Liu T. Hydrogen sulfide-induced itch requires activation of Ca<sub>v<\/sub>3.2 T-type calcium channel in mice. <i>Sci. Rep.<\/i>, <b>5<\/b>, 16768 (2015).","DOI":"10.1038\/srep16768"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ghazisaeidi S, Muley MM, Salter MW. Neuropathic pain: mechanisms, sex differences, and potential therapies for a global problem. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>63<\/b>, 565\u2013583 (2023).","DOI":"10.1146\/annurev-pharmtox-051421-112259"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Athnaiel O, Davidson N, Mangat J, Nasr NF, Knezevic NN. Gonadal hormone changes with aging and their impact on chronic pain. <i>Cells<\/i>, <b>14<\/b>, 123 (2025).","DOI":"10.3390\/cells14020123"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Barcelon E, Chung S, Lee J, Lee SJ. Sexual dimorphism in the mechanism of pain central sensitization. <i>Cells<\/i>, <b>12<\/b>, 2028 (2023).","DOI":"10.3390\/cells12162028"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Saika F, Uta D, Fukazawa Y, Hino Y, Hatano Y, Kishioka S, Nawa H, Hino S, Suzuki K, Kiguchi N. Androgen receptors expressed in the primary sensory neurons regulate mechanical pain sensitivity. <i>Pain<\/i>, <b>166<\/b>, e746\u2013e757 (2025).","DOI":"10.1097\/j.pain.0000000000003736"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sarajari S, Oblinger MM. Estrogen effects on pain sensitivity and neuropeptide expression in rat sensory neurons. <i>Exp. Neurol.<\/i>, <b>224<\/b>, 163\u2013169 (2010).","DOI":"10.1016\/j.expneurol.2010.03.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: a retrospective study in Japan. <i>PLOS ONE<\/i>, <b>16<\/b>, e0261473 (2021).","DOI":"10.1371\/journal.pone.0261473"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Miyamoto T, Hiramoto S, Kanto A, Tsubota M, Fujitani M, Fukuyama H, Hatanaka S, Sekiguchi F, Koizumi Y, Kawabata A. Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study. <i>J. Pharmacol. Sci.<\/i>, <b>146<\/b>, 49\u201357 (2021).","DOI":"10.1016\/j.jphs.2021.03.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Takanami K, Uta D, Matsuda KI, Kawata M, Carstens E, Sakamoto T, Sakamoto H. Estrogens influence female itch sensitivity <i>via<\/i> the spinal gastrin-releasing peptide receptor neurons. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>118<\/b>, e2103536118 (2021).","DOI":"10.1073\/pnas.2103536118"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Jin J, Li L, Wang Y, Li K, Qian A, Li W, Liu Q, Wen C, Liu Q, Yan G, Xue F. Estrogen alleviates acute and chronic itch in mice. <i>Exp. Ther. Med.<\/i>, <b>25<\/b>, 255 (2023).","DOI":"10.3892\/etm.2023.11954"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kasanami Y, Ishikawa C, Kino T, Chonan M, Toyooka N, Takashima Y, Iba Y, Sekiguchi F, Tsubota M, Ohkubo T, Yoshida S, Kawase A, Okada T, Kawabata A. Discovery of pimozide derivatives as novel T-type calcium channel inhibitors with little binding affinity to dopamine D<sub>2<\/sub> receptors for treatment of somatic and visceral pain. <i>Eur. J. Med. Chem.<\/i>, <b>243<\/b>, 114716 (2022).","DOI":"10.1016\/j.ejmech.2022.114716"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shimada SG, LaMotte RH. Behavioral differentiation between itch and pain in mouse. <i>Pain<\/i>, <b>139<\/b>, 681\u2013687 (2008).","DOI":"10.1016\/j.pain.2008.08.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maroteaux MJ, Noccioli CT, Daniel JM, Schrader LA. Rapid and local neuroestrogen synthesis supports long-term potentiation of hippocampal Schaffer collaterals-cornu ammonis 1 synapse in ovariectomized mice. <i>J. Neuroendocrinol.<\/i>, <b>36<\/b>, e13450 (2024).","DOI":"10.1111\/jne.13450"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Andreucci E, Francica P, Fearns A, Martin LA, Chiarugi P, Isacke CM, Morandi A. Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts. <i>Oncotarget<\/i>, <b>7<\/b>, 80543\u201380553 (2016).","DOI":"10.18632\/oncotarget.11826"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ahn JW, Kim SE, Kim DY, Jeong I, Kim S, Chung S, Lee SE. Cav3.2 T-type calcium channel mediates acute itch and contributes to chronic itch and inflammation in experimental atopic dermatitis. <i>J. Invest. Dermatol.<\/i>, <b>144<\/b>, 612\u2013620 e616 (2024).","DOI":"10.1016\/j.jid.2023.07.029"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Watanabe Y, Makino E, Tajiki-Nishino R, Koyama A, Tajima H, Ishimota M, Fukuyama T. Involvement of estrogen receptor alpha in pro-pruritic and pro-inflammatory responses in a mouse model of allergic dermatitis. <i>Toxicol. Appl. Pharmacol.<\/i>, <b>355<\/b>, 226\u2013237 (2018).","DOI":"10.1016\/j.taap.2018.07.008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. <i>J. Am. Acad. Dermatol.<\/i>, <b>53<\/b>, 555\u2013568, quiz, 569\u2013572 (2005).","DOI":"10.1016\/j.jaad.2004.08.039"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Pi\u00e9rard-Franchimont C, Letawe C, Goffin V, Pierard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. <i>Maturitas<\/i>, <b>22<\/b>, 151\u2013154 (1995).","DOI":"10.1016\/0378-5122(95)00924-A"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Castelo-Branco C, Duran M, Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy. <i>Maturitas<\/i>, <b>15<\/b>, 113\u2013119 (1992).","DOI":"10.1016\/0378-5122(92)90245-Y"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. <i>Int. J. Gynaecol. Obstet.<\/i>, <b>68<\/b>, 35\u201341 (2000).","DOI":"10.1016\/S0020-7292(99)00166-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kanda N, Hoashi T, Saeki H. The roles of sex hormones in the course of atopic dermatitis. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 4660 (2019).","DOI":"10.3390\/ijms20194660"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00671\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:50:10Z","timestamp":1773460210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00671\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00671","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"article-number":"b25-00671"}}